Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor AP-2 gamma is a DNA-binding transcription factor, encoded by the gene TFAP2C, and is a member of the AP-2 family. It regulates gene expression by binding to specific enhancer DNA sequences (5'-GCCNNNGGC-3') and can function as a homodimer or heterodimer with other AP-2 family members. TFAP2C plays a crucial role during early embryogenesis, particularly in morphogenesis and the development of multiple tissues, notably the placenta, eyes, facial structures, and neural tube. It acts as both an activator and repressor of gene expression, activating genes essential for differentiation and repressing others such as MYC and CD44. Dysregulation or mutation can lead to developmental syndromes (e.g., branchiooculofacial syndrome) or contribute to tumorigenesis, particularly in breast cancer, where it is known to regulate estrogen receptor pathways and serve as a biomarker of tumor subtype and prognosis[1][2][4].
Modulation of transcriptional activity via DNA binding and interaction with enhancer elements. Regulation of downstream genes implicated in tumor progression and embryogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor AP-2 gamma (TFAP2C).